Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant	CMV Viremia; Heart Transplant Failure and Rejection; Heart Transplant Infection	Recruiting	Phase 2 / Phase 3	2026-10-02		NCT07079735

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Columbia University	375
Cornell University	41

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Columbia University/NYP Milstein Hospital	New York	United States	1
NYP-Weill Cornell	New York	United States	1

Clinical trials